Corvus Pharmaceuticals
CRVS
CRVS
46 hedge funds and large institutions have $18.5M invested in Corvus Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less funds holding
Funds holding: 56 → 46 (-10)
59% less capital invested
Capital invested by funds: $44.9M → $18.5M (-$26.4M)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Holders
46
Holding in Top 10
1
Calls
$80K
Puts
$60K
Top Buyers
| 1 | +$506K | |
| 2 | +$198K | |
| 3 | +$171K | |
| 4 |
Renaissance Technologies
New York
|
+$61.2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$19.9K |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$837K | |
| 3 | -$813K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$663K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$185K |